Immunoblue

Developer of nanoimmunotherapies for cancer treatment using nanotechnology and immunotherapy

placeBethesda, Maryland, United States calendar_todayFounded 2016 language immunoblue.com

Social engagement

Social engagement: 150 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

3 Mar 2026
Expansion
Baltimore at University of Maryland BioPark
Coming soon